Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
Clinical trial NCT00056641 · COMPLETED
Trial details
- NCT number
- NCT00056641
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-18
- Primary completion
- 2004-01-27
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.